» Articles » PMID: 36612205

Does the Choice of Anaesthesia Affect Cancer? A Molecular Crosstalk Between Theory and Practice

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2023 Jan 8
PMID 36612205
Authors
Affiliations
Soon will be listed here.
Abstract

In recent years, there has been an increasing scientific interest in the interaction between anaesthesia and cancer development. Retrospective studies show that the choice of anaesthetics may influence cancer outcome and cancer recurrence; however, these studies show contradictory results. Recently, some large randomized clinical trials have been completed, yet they show no significant effect of anaesthetics on cancer outcomes. In this scoping review, we compiled a body of in vivo and in vitro studies with the goal of evaluating the biological effects of anaesthetics on cancer cells in comparison to clinical effects as described in recent studies. It was found that sevoflurane, propofol, opioids and lidocaine are likely to display direct biological effects on cancer cells; however, significant effects are only found in studies with exposure to high concentrations of anaesthetics and/or during longer exposure times. When compared to clinical data, these differences in exposure and dose-effect relation, as well as tissue selectivity, population selection and unclear anaesthetic dosing protocols might explain the lack of outcome.

Citing Articles

Anesthesia-related postoperative oncological surgical outcomes: a comparison of total intravenous anesthesia and volatile anesthesia. A meta-analysis.

Yan Q, Liang H, Yin H, Ye X Wideochir Inne Tech Maloinwazyjne. 2024; 18(4):612-624.

PMID: 38239582 PMC: 10793154. DOI: 10.5114/wiitm.2023.133916.

References
1.
Zylla D, Gourley B, Vang D, Jackson S, Boatman S, Lindgren B . Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer. Cancer. 2013; 119(23):4103-10. PMC: 3833881. DOI: 10.1002/cncr.28345. View

2.
Chen X, Wu Q, You L, Chen S, Zhu M, Miao C . Propofol attenuates pancreatic cancer malignant potential via inhibition of NMDA receptor. Eur J Pharmacol. 2016; 795:150-159. DOI: 10.1016/j.ejphar.2016.12.017. View

3.
Ye Z, Jingzhong L, Yangbo L, Lei C, Jiandong Y . Propofol inhibits proliferation and invasion of osteosarcoma cells by regulation of microRNA-143 expression. Oncol Res. 2014; 21(4):201-7. DOI: 10.3727/096504014X13890370410203. View

4.
Gao H, Chakraborty G, Lee-Lim A, Mo Q, Decker M, Vonica A . The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites. Cell. 2012; 150(4):764-79. PMC: 3711709. DOI: 10.1016/j.cell.2012.06.035. View

5.
Xu J, Xu W, Zhu J . Propofol suppresses proliferation and invasion of glioma cells by upregulating microRNA-218 expression. Mol Med Rep. 2015; 12(4):4815-20. PMC: 4581763. DOI: 10.3892/mmr.2015.4014. View